Request for Covid-19 Impact Assessment of this Report
The United States Cyproheptadine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cyproheptadine market, reaching US$ million by the year 2028. As for the Europe Cyproheptadine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cyproheptadine players cover MSD, Aero-Chem, Allena Pharmaceuticals, and Caillon and Hamonet, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyproheptadine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Patent
Generic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Store
On-line
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
MSD
Aero-Chem
Allena Pharmaceuticals
Caillon and Hamonet
Teriak
Arena Pharmaceuticals
Pharma Arte
Fu Yuan Pharmaceutical
Panbiotic Laboratories
Royal Pharma
Novartis
General Pharma
Qualipharm
Faes Pharma
Apex Pharma
Cipla Medpro South Africa
Abbott
Kalbe
Laboratoires Servier
Medphano
Nichi-Iko Pharmaceutical
Teva
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cyproheptadine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cyproheptadine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cyproheptadine by Country/Region, 2017, 2022 & 2028
2.2 Cyproheptadine Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Cyproheptadine Sales by Type
2.3.1 Global Cyproheptadine Sales Market Share by Type (2017-2022)
2.3.2 Global Cyproheptadine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cyproheptadine Sale Price by Type (2017-2022)
2.4 Cyproheptadine Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Cyproheptadine Sales by Application
2.5.1 Global Cyproheptadine Sale Market Share by Application (2017-2022)
2.5.2 Global Cyproheptadine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cyproheptadine Sale Price by Application (2017-2022)
3 Global Cyproheptadine by Company
3.1 Global Cyproheptadine Breakdown Data by Company
3.1.1 Global Cyproheptadine Annual Sales by Company (2020-2022)
3.1.2 Global Cyproheptadine Sales Market Share by Company (2020-2022)
3.2 Global Cyproheptadine Annual Revenue by Company (2020-2022)
3.2.1 Global Cyproheptadine Revenue by Company (2020-2022)
3.2.2 Global Cyproheptadine Revenue Market Share by Company (2020-2022)
3.3 Global Cyproheptadine Sale Price by Company
3.4 Key Manufacturers Cyproheptadine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyproheptadine Product Location Distribution
3.4.2 Players Cyproheptadine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cyproheptadine by Geographic Region
4.1 World Historic Cyproheptadine Market Size by Geographic Region (2017-2022)
4.1.1 Global Cyproheptadine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cyproheptadine Annual Revenue by Geographic Region
4.2 World Historic Cyproheptadine Market Size by Country/Region (2017-2022)
4.2.1 Global Cyproheptadine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cyproheptadine Annual Revenue by Country/Region
4.3 Americas Cyproheptadine Sales Growth
4.4 APAC Cyproheptadine Sales Growth
4.5 Europe Cyproheptadine Sales Growth
4.6 Middle East & Africa Cyproheptadine Sales Growth
5 Americas
5.1 Americas Cyproheptadine Sales by Country
5.1.1 Americas Cyproheptadine Sales by Country (2017-2022)
5.1.2 Americas Cyproheptadine Revenue by Country (2017-2022)
5.2 Americas Cyproheptadine Sales by Type
5.3 Americas Cyproheptadine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyproheptadine Sales by Region
6.1.1 APAC Cyproheptadine Sales by Region (2017-2022)
6.1.2 APAC Cyproheptadine Revenue by Region (2017-2022)
6.2 APAC Cyproheptadine Sales by Type
6.3 APAC Cyproheptadine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cyproheptadine by Country
7.1.1 Europe Cyproheptadine Sales by Country (2017-2022)
7.1.2 Europe Cyproheptadine Revenue by Country (2017-2022)
7.2 Europe Cyproheptadine Sales by Type
7.3 Europe Cyproheptadine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cyproheptadine by Country
8.1.1 Middle East & Africa Cyproheptadine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cyproheptadine Revenue by Country (2017-2022)
8.2 Middle East & Africa Cyproheptadine Sales by Type
8.3 Middle East & Africa Cyproheptadine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyproheptadine
10.3 Manufacturing Process Analysis of Cyproheptadine
10.4 Industry Chain Structure of Cyproheptadine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyproheptadine Distributors
11.3 Cyproheptadine Customer
12 World Forecast Review for Cyproheptadine by Geographic Region
12.1 Global Cyproheptadine Market Size Forecast by Region
12.1.1 Global Cyproheptadine Forecast by Region (2023-2028)
12.1.2 Global Cyproheptadine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cyproheptadine Forecast by Type
12.7 Global Cyproheptadine Forecast by Application
13 Key Players Analysis
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD Cyproheptadine Product Offered
13.1.3 MSD Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Aero-Chem
13.2.1 Aero-Chem Company Information
13.2.2 Aero-Chem Cyproheptadine Product Offered
13.2.3 Aero-Chem Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aero-Chem Main Business Overview
13.2.5 Aero-Chem Latest Developments
13.3 Allena Pharmaceuticals
13.3.1 Allena Pharmaceuticals Company Information
13.3.2 Allena Pharmaceuticals Cyproheptadine Product Offered
13.3.3 Allena Pharmaceuticals Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Allena Pharmaceuticals Main Business Overview
13.3.5 Allena Pharmaceuticals Latest Developments
13.4 Caillon and Hamonet
13.4.1 Caillon and Hamonet Company Information
13.4.2 Caillon and Hamonet Cyproheptadine Product Offered
13.4.3 Caillon and Hamonet Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Caillon and Hamonet Main Business Overview
13.4.5 Caillon and Hamonet Latest Developments
13.5 Teriak
13.5.1 Teriak Company Information
13.5.2 Teriak Cyproheptadine Product Offered
13.5.3 Teriak Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teriak Main Business Overview
13.5.5 Teriak Latest Developments
13.6 Arena Pharmaceuticals
13.6.1 Arena Pharmaceuticals Company Information
13.6.2 Arena Pharmaceuticals Cyproheptadine Product Offered
13.6.3 Arena Pharmaceuticals Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Arena Pharmaceuticals Main Business Overview
13.6.5 Arena Pharmaceuticals Latest Developments
13.7 Pharma Arte
13.7.1 Pharma Arte Company Information
13.7.2 Pharma Arte Cyproheptadine Product Offered
13.7.3 Pharma Arte Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pharma Arte Main Business Overview
13.7.5 Pharma Arte Latest Developments
13.8 Fu Yuan Pharmaceutical
13.8.1 Fu Yuan Pharmaceutical Company Information
13.8.2 Fu Yuan Pharmaceutical Cyproheptadine Product Offered
13.8.3 Fu Yuan Pharmaceutical Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Fu Yuan Pharmaceutical Main Business Overview
13.8.5 Fu Yuan Pharmaceutical Latest Developments
13.9 Panbiotic Laboratories
13.9.1 Panbiotic Laboratories Company Information
13.9.2 Panbiotic Laboratories Cyproheptadine Product Offered
13.9.3 Panbiotic Laboratories Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Panbiotic Laboratories Main Business Overview
13.9.5 Panbiotic Laboratories Latest Developments
13.10 Royal Pharma
13.10.1 Royal Pharma Company Information
13.10.2 Royal Pharma Cyproheptadine Product Offered
13.10.3 Royal Pharma Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Royal Pharma Main Business Overview
13.10.5 Royal Pharma Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Cyproheptadine Product Offered
13.11.3 Novartis Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 General Pharma
13.12.1 General Pharma Company Information
13.12.2 General Pharma Cyproheptadine Product Offered
13.12.3 General Pharma Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 General Pharma Main Business Overview
13.12.5 General Pharma Latest Developments
13.13 Qualipharm
13.13.1 Qualipharm Company Information
13.13.2 Qualipharm Cyproheptadine Product Offered
13.13.3 Qualipharm Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Qualipharm Main Business Overview
13.13.5 Qualipharm Latest Developments
13.14 Faes Pharma
13.14.1 Faes Pharma Company Information
13.14.2 Faes Pharma Cyproheptadine Product Offered
13.14.3 Faes Pharma Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Faes Pharma Main Business Overview
13.14.5 Faes Pharma Latest Developments
13.15 Apex Pharma
13.15.1 Apex Pharma Company Information
13.15.2 Apex Pharma Cyproheptadine Product Offered
13.15.3 Apex Pharma Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Apex Pharma Main Business Overview
13.15.5 Apex Pharma Latest Developments
13.16 Cipla Medpro South Africa
13.16.1 Cipla Medpro South Africa Company Information
13.16.2 Cipla Medpro South Africa Cyproheptadine Product Offered
13.16.3 Cipla Medpro South Africa Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Cipla Medpro South Africa Main Business Overview
13.16.5 Cipla Medpro South Africa Latest Developments
13.17 Abbott
13.17.1 Abbott Company Information
13.17.2 Abbott Cyproheptadine Product Offered
13.17.3 Abbott Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Abbott Main Business Overview
13.17.5 Abbott Latest Developments
13.18 Kalbe
13.18.1 Kalbe Company Information
13.18.2 Kalbe Cyproheptadine Product Offered
13.18.3 Kalbe Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Kalbe Main Business Overview
13.18.5 Kalbe Latest Developments
13.19 Laboratoires Servier
13.19.1 Laboratoires Servier Company Information
13.19.2 Laboratoires Servier Cyproheptadine Product Offered
13.19.3 Laboratoires Servier Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Laboratoires Servier Main Business Overview
13.19.5 Laboratoires Servier Latest Developments
13.20 Medphano
13.20.1 Medphano Company Information
13.20.2 Medphano Cyproheptadine Product Offered
13.20.3 Medphano Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Medphano Main Business Overview
13.20.5 Medphano Latest Developments
13.21 Nichi-Iko Pharmaceutical
13.21.1 Nichi-Iko Pharmaceutical Company Information
13.21.2 Nichi-Iko Pharmaceutical Cyproheptadine Product Offered
13.21.3 Nichi-Iko Pharmaceutical Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Nichi-Iko Pharmaceutical Main Business Overview
13.21.5 Nichi-Iko Pharmaceutical Latest Developments
13.22 Teva
13.22.1 Teva Company Information
13.22.2 Teva Cyproheptadine Product Offered
13.22.3 Teva Cyproheptadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Teva Main Business Overview
13.22.5 Teva Latest Developments
14 Research Findings and Conclusion
Table 1. Cyproheptadine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cyproheptadine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Cyproheptadine Sales by Type (2017-2022) & (K Units)
Table 6. Global Cyproheptadine Sales Market Share by Type (2017-2022)
Table 7. Global Cyproheptadine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Cyproheptadine Revenue Market Share by Type (2017-2022)
Table 9. Global Cyproheptadine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Cyproheptadine Sales by Application (2017-2022) & (K Units)
Table 11. Global Cyproheptadine Sales Market Share by Application (2017-2022)
Table 12. Global Cyproheptadine Revenue by Application (2017-2022)
Table 13. Global Cyproheptadine Revenue Market Share by Application (2017-2022)
Table 14. Global Cyproheptadine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Cyproheptadine Sales by Company (2020-2022) & (K Units)
Table 16. Global Cyproheptadine Sales Market Share by Company (2020-2022)
Table 17. Global Cyproheptadine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Cyproheptadine Revenue Market Share by Company (2020-2022)
Table 19. Global Cyproheptadine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Cyproheptadine Producing Area Distribution and Sales Area
Table 21. Players Cyproheptadine Products Offered
Table 22. Cyproheptadine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cyproheptadine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Cyproheptadine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Cyproheptadine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Cyproheptadine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Cyproheptadine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Cyproheptadine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Cyproheptadine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Cyproheptadine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Cyproheptadine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Cyproheptadine Sales Market Share by Country (2017-2022)
Table 35. Americas Cyproheptadine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Cyproheptadine Revenue Market Share by Country (2017-2022)
Table 37. Americas Cyproheptadine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Cyproheptadine Sales Market Share by Type (2017-2022)
Table 39. Americas Cyproheptadine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Cyproheptadine Sales Market Share by Application (2017-2022)
Table 41. APAC Cyproheptadine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Cyproheptadine Sales Market Share by Region (2017-2022)
Table 43. APAC Cyproheptadine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Cyproheptadine Revenue Market Share by Region (2017-2022)
Table 45. APAC Cyproheptadine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Cyproheptadine Sales Market Share by Type (2017-2022)
Table 47. APAC Cyproheptadine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Cyproheptadine Sales Market Share by Application (2017-2022)
Table 49. Europe Cyproheptadine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Cyproheptadine Sales Market Share by Country (2017-2022)
Table 51. Europe Cyproheptadine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Cyproheptadine Revenue Market Share by Country (2017-2022)
Table 53. Europe Cyproheptadine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Cyproheptadine Sales Market Share by Type (2017-2022)
Table 55. Europe Cyproheptadine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Cyproheptadine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Cyproheptadine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Cyproheptadine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Cyproheptadine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Cyproheptadine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cyproheptadine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Cyproheptadine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Cyproheptadine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Cyproheptadine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Cyproheptadine
Table 66. Key Market Challenges & Risks of Cyproheptadine
Table 67. Key Industry Trends of Cyproheptadine
Table 68. Cyproheptadine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Cyproheptadine Distributors List
Table 71. Cyproheptadine Customer List
Table 72. Global Cyproheptadine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Cyproheptadine Sales Market Forecast by Region
Table 74. Global Cyproheptadine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Cyproheptadine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Cyproheptadine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Cyproheptadine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Cyproheptadine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Cyproheptadine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Cyproheptadine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Cyproheptadine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Cyproheptadine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Cyproheptadine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Cyproheptadine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Cyproheptadine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Cyproheptadine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Cyproheptadine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Cyproheptadine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Cyproheptadine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Cyproheptadine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Cyproheptadine Revenue Market Share Forecast by Application (2023-2028)
Table 92. MSD Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD Cyproheptadine Product Offered
Table 94. MSD Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. MSD Main Business
Table 96. MSD Latest Developments
Table 97. Aero-Chem Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 98. Aero-Chem Cyproheptadine Product Offered
Table 99. Aero-Chem Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Aero-Chem Main Business
Table 101. Aero-Chem Latest Developments
Table 102. Allena Pharmaceuticals Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 103. Allena Pharmaceuticals Cyproheptadine Product Offered
Table 104. Allena Pharmaceuticals Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Allena Pharmaceuticals Main Business
Table 106. Allena Pharmaceuticals Latest Developments
Table 107. Caillon and Hamonet Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 108. Caillon and Hamonet Cyproheptadine Product Offered
Table 109. Caillon and Hamonet Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Caillon and Hamonet Main Business
Table 111. Caillon and Hamonet Latest Developments
Table 112. Teriak Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 113. Teriak Cyproheptadine Product Offered
Table 114. Teriak Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Teriak Main Business
Table 116. Teriak Latest Developments
Table 117. Arena Pharmaceuticals Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 118. Arena Pharmaceuticals Cyproheptadine Product Offered
Table 119. Arena Pharmaceuticals Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Arena Pharmaceuticals Main Business
Table 121. Arena Pharmaceuticals Latest Developments
Table 122. Pharma Arte Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 123. Pharma Arte Cyproheptadine Product Offered
Table 124. Pharma Arte Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Pharma Arte Main Business
Table 126. Pharma Arte Latest Developments
Table 127. Fu Yuan Pharmaceutical Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 128. Fu Yuan Pharmaceutical Cyproheptadine Product Offered
Table 129. Fu Yuan Pharmaceutical Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Fu Yuan Pharmaceutical Main Business
Table 131. Fu Yuan Pharmaceutical Latest Developments
Table 132. Panbiotic Laboratories Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 133. Panbiotic Laboratories Cyproheptadine Product Offered
Table 134. Panbiotic Laboratories Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Panbiotic Laboratories Main Business
Table 136. Panbiotic Laboratories Latest Developments
Table 137. Royal Pharma Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 138. Royal Pharma Cyproheptadine Product Offered
Table 139. Royal Pharma Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Royal Pharma Main Business
Table 141. Royal Pharma Latest Developments
Table 142. Novartis Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 143. Novartis Cyproheptadine Product Offered
Table 144. Novartis Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Novartis Main Business
Table 146. Novartis Latest Developments
Table 147. General Pharma Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 148. General Pharma Cyproheptadine Product Offered
Table 149. General Pharma Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. General Pharma Main Business
Table 151. General Pharma Latest Developments
Table 152. Qualipharm Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 153. Qualipharm Cyproheptadine Product Offered
Table 154. Qualipharm Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Qualipharm Main Business
Table 156. Qualipharm Latest Developments
Table 157. Faes Pharma Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 158. Faes Pharma Cyproheptadine Product Offered
Table 159. Faes Pharma Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Faes Pharma Main Business
Table 161. Faes Pharma Latest Developments
Table 162. Apex Pharma Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 163. Apex Pharma Cyproheptadine Product Offered
Table 164. Apex Pharma Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Apex Pharma Main Business
Table 166. Apex Pharma Latest Developments
Table 167. Cipla Medpro South Africa Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 168. Cipla Medpro South Africa Cyproheptadine Product Offered
Table 169. Cipla Medpro South Africa Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Cipla Medpro South Africa Main Business
Table 171. Cipla Medpro South Africa Latest Developments
Table 172. Abbott Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 173. Abbott Cyproheptadine Product Offered
Table 174. Abbott Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Abbott Main Business
Table 176. Abbott Latest Developments
Table 177. Kalbe Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 178. Kalbe Cyproheptadine Product Offered
Table 179. Kalbe Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Kalbe Main Business
Table 181. Kalbe Latest Developments
Table 182. Laboratoires Servier Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 183. Laboratoires Servier Cyproheptadine Product Offered
Table 184. Laboratoires Servier Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Laboratoires Servier Main Business
Table 186. Laboratoires Servier Latest Developments
Table 187. Medphano Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 188. Medphano Cyproheptadine Product Offered
Table 189. Medphano Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Medphano Main Business
Table 191. Medphano Latest Developments
Table 192. Nichi-Iko Pharmaceutical Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 193. Nichi-Iko Pharmaceutical Cyproheptadine Product Offered
Table 194. Nichi-Iko Pharmaceutical Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Nichi-Iko Pharmaceutical Main Business
Table 196. Nichi-Iko Pharmaceutical Latest Developments
Table 197. Teva Basic Information, Cyproheptadine Manufacturing Base, Sales Area and Its Competitors
Table 198. Teva Cyproheptadine Product Offered
Table 199. Teva Cyproheptadine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 200. Teva Main Business
Table 201. Teva Latest Developments
List of Figures
Figure 1. Picture of Cyproheptadine
Figure 2. Cyproheptadine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyproheptadine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cyproheptadine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cyproheptadine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Cyproheptadine Sales Market Share by Type in 2021
Figure 12. Global Cyproheptadine Revenue Market Share by Type (2017-2022)
Figure 13. Cyproheptadine Consumed in Hospital
Figure 14. Global Cyproheptadine Market: Hospital (2017-2022) & (K Units)
Figure 15. Cyproheptadine Consumed in Drug Store
Figure 16. Global Cyproheptadine Market: Drug Store (2017-2022) & (K Units)
Figure 17. Cyproheptadine Consumed in On-line
Figure 18. Global Cyproheptadine Market: On-line (2017-2022) & (K Units)
Figure 19. Global Cyproheptadine Sales Market Share by Application (2017-2022)
Figure 20. Global Cyproheptadine Revenue Market Share by Application in 2021
Figure 21. Cyproheptadine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Cyproheptadine Revenue Market Share by Company in 2021
Figure 23. Global Cyproheptadine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Cyproheptadine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Cyproheptadine Sales Market Share by Region (2017-2022)
Figure 26. Global Cyproheptadine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Cyproheptadine Sales 2017-2022 (K Units)
Figure 28. Americas Cyproheptadine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Cyproheptadine Sales 2017-2022 (K Units)
Figure 30. APAC Cyproheptadine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Cyproheptadine Sales 2017-2022 (K Units)
Figure 32. Europe Cyproheptadine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Cyproheptadine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Cyproheptadine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Cyproheptadine Sales Market Share by Country in 2021
Figure 36. Americas Cyproheptadine Revenue Market Share by Country in 2021
Figure 37. United States Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Cyproheptadine Sales Market Share by Region in 2021
Figure 42. APAC Cyproheptadine Revenue Market Share by Regions in 2021
Figure 43. China Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Cyproheptadine Sales Market Share by Country in 2021
Figure 50. Europe Cyproheptadine Revenue Market Share by Country in 2021
Figure 51. Germany Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Cyproheptadine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Cyproheptadine Revenue Market Share by Country in 2021
Figure 58. Egypt Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Cyproheptadine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Cyproheptadine in 2021
Figure 64. Manufacturing Process Analysis of Cyproheptadine
Figure 65. Industry Chain Structure of Cyproheptadine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...